Medicine & Life Sciences
Mexico
100%
Uropathogenic Escherichia coli
50%
Klebsiella pneumoniae
42%
Escherichia coli
36%
Acinetobacter baumannii
35%
carbapenemase
27%
Carbapenems
27%
Microbial Drug Resistance
24%
Urinary Tract Infections
24%
Pseudomonas aeruginosa
21%
Genes
21%
fructose-6-phosphate phosphoketolase
18%
phosphoketolase
18%
Fluoroquinolones
17%
Tuberculosis
17%
Meropenem
16%
Drug Resistance
16%
Phenotype
16%
Virulence
15%
Sulfamethoxazole Drug Combination Trimethoprim
14%
Cefepime
14%
Anti-Bacterial Agents
14%
Genotype
13%
Interferon-gamma Release Tests
13%
Mycobacterium tuberculosis
13%
Age Groups
12%
Bacterial Drug Resistance
12%
Enterococcus faecium
12%
Genomic Islands
12%
Norovirus
11%
Lactobacillus reuteri
11%
Pediatrics
11%
Coronavirus
11%
Cephalosporins
11%
Extraintestinal Pathogenic Escherichia coli
11%
Levofloxacin
11%
Ciprofloxacin
11%
Gentamicins
10%
Staphylococcus aureus
10%
Phylogeny
10%
Watchful Waiting
10%
Lactobacillus
10%
beta-lactamase TEM-3
10%
Mycobacterium bovis
9%
Negative Results
9%
Pandemics
9%
Minisatellite Repeats
9%
Gold
9%
Aminoglycosides
9%
Plasmids
9%
Agriculture & Biology
Norovirus
12%
cerebrospinal fluid
10%
drug resistance
10%
Mexico
8%
fluids
6%
incidence
6%
carbapenems
6%
Streptococcus pneumoniae
5%
pathogens
5%
blood
5%